These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


176 related items for PubMed ID: 35390310

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Expression of cytokeratins 7 and 20 in ovarian neoplasia.
    Cathro HP, Stoler MH.
    Am J Clin Pathol; 2002 Jun; 117(6):944-51. PubMed ID: 12047147
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody.
    Bayrak R, Haltas H, Yenidunya S.
    Diagn Pathol; 2012 Jan 23; 7():9. PubMed ID: 22268990
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Identification of relevant prognostic values of cytokeratin 20 and cytokeratin 7 expressions in lung cancer.
    Luo HT, Liang CX, Luo RC, Gu WG.
    Biosci Rep; 2017 Dec 22; 37(6):. PubMed ID: 28827446
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Immunoprofile of ovarian tumors with putative transitional cell (urothelial) differentiation using novel urothelial markers: histogenetic and diagnostic implications.
    Logani S, Oliva E, Amin MB, Folpe AL, Cohen C, Young RH.
    Am J Surg Pathol; 2003 Nov 22; 27(11):1434-41. PubMed ID: 14576476
    [Abstract] [Full Text] [Related]

  • 37. Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases.
    Vang R, Gown AM, Barry TS, Wheeler DT, Yemelyanova A, Seidman JD, Ronnett BM.
    Am J Surg Pathol; 2006 Sep 22; 30(9):1130-9. PubMed ID: 16931958
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. CDX2, cytokeratins 7 and 20 immunoreactivity in rectal adenocarcinoma.
    Saad RS, Silverman JF, Khalifa MA, Rowsell C.
    Appl Immunohistochem Mol Morphol; 2009 May 22; 17(3):196-201. PubMed ID: 19098678
    [Abstract] [Full Text] [Related]

  • 40. Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma.
    Kennedy MT, Jordan RC, Berean KW, Perez-Ordoñez B.
    J Clin Pathol; 2004 Sep 22; 57(9):932-7. PubMed ID: 15333652
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.